Biopharma company files IND with U.S. FDA for cystic fibrosis treatment.
Publication: Vaccine Weekly
Publication Date: 29-DEC-04
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
2004 DEC 29 - (NewsRx.com & NewsRx.net) -- Medical Discoveries, Inc., (BULLETIN BOARD: MLSC) announced that it has filed an investigational new drug (IND) application with the U.S. Food and Drug Administration (FDA) for a phase I clinical trial of the company's proprietary drug MDI-P in late-term cystic fibrosis...
Read the full article for free courtesy of your local library.
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
